(NTLA) Intellia Therapeutics - Performance -52.8% in 12m
NTLA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-64.06%
#90 in Peer-Group
Rel. Strength
8.34%
#7035 in Stock-Universe
Total Return 12m
-52.81%
#136 in Peer-Group
Total Return 5y
-52.25%
#65 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 27.36 USD |
| 52 Week Low | 6.28 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 96.57 |
| Buy/Sell Signal +-5 | 0.47 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: NTLA (-52.8%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: NTLA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NTLA
| Total Return (including Dividends) | NTLA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 40.03% | 3.36% | 5.25% |
| 3 Months | 61.99% | 15.73% | 24.13% |
| 12 Months | -52.81% | -7.02% | 14.15% |
| 5 Years | -52.25% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | NTLA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 89.8% | 4.4% | 81% |
| 3 Months | 69.8% | 78.8% | 96.9% |
| 12 Months | -93.3% | -85.8% | 44.9% |
| 5 Years | -66.5% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th94.00 | 35.48% | 33.05% |
| 3 Month | %th84.00 | 39.97% | 30.50% |
| 12 Month | %th32.50 | -49.25% | -58.66% |
| 5 Years | %th68.00 | -36.99% | -77.46% |
FAQs
Does Intellia Therapeutics (NTLA) outperform the market?
No,
over the last 12 months NTLA made -52.81%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months NTLA made 61.99%, while XBI made 15.73%.
Performance Comparison NTLA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
NTLA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 10.6% | 34.8% | -21.8% | -67% |
| US NASDAQ 100 | QQQ | 10.9% | 34.7% | -22.4% | -66% |
| German DAX 40 | DAX | 12.8% | 41.4% | -33.9% | -82% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 10.8% | 36.8% | -25.2% | -73% |
| Hongkong Hang Seng | HSI | 11% | 34% | -41.2% | -91% |
| India NIFTY 50 | INDA | 12.5% | 36.6% | -22.1% | -52% |
| Brasil Bovespa | EWZ | 8.2% | 31.2% | -46.8% | -63% |
NTLA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 12% | 34.1% | -25.9% | -77% |
| Consumer Discretionary | XLY | 11.1% | 36.9% | -14.1% | -71% |
| Consumer Staples | XLP | 10.3% | 39.4% | -23.4% | -62% |
| Energy | XLE | 10.3% | 33% | -17.6% | -53% |
| Financial | XLF | 9.9% | 35% | -26.7% | -83% |
| Health Care | XLV | 11.2% | 37.9% | -14.4% | -48% |
| Industrial | XLI | 10.6% | 35.8% | -29.6% | -78% |
| Materials | XLB | 8.4% | 35.8% | -26.3% | -59% |
| Real Estate | XLRE | 10.7% | 39.1% | -21.5% | -66% |
| Technology | XLK | 9.9% | 31.3% | -24.1% | -64% |
| Utilities | XLU | 11.7% | 38.2% | -25% | -76% |
| Aerospace & Defense | XAR | 12.8% | 33% | -40.3% | -102% |
| Biotech | XBI | 9.7% | 36.7% | -8.5% | -46% |
| Homebuilder | XHB | 8.1% | 33% | -14.6% | -58% |
| Retail | XRT | 8.1% | 35% | -17.4% | -64% |
NTLA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 9.7% | 31.6% | -13.4% | -45% |
| Natural Gas | UNG | 20.1% | 49.9% | -5% | -51% |
| Gold | GLD | 10.4% | 41.2% | -42.4% | -92% |
| Silver | SLV | 9.6% | 33.1% | -39.1% | -70% |
| Copper | CPER | 11.6% | 35.4% | -38.8% | -64% |
NTLA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 12.5% | 39% | -18.3% | -51% |
| iShares High Yield Corp. Bond | HYG | 11.8% | 38.4% | -20.7% | -63% |